Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Stella Aslanyan"'
Autor:
Philip J. Mease, Herbert Kellner, Akimichi Morita, Alan J. Kivitz, Stella Aslanyan, Steven J. Padula, Andrew S. Topp, Ann Eldred, Frank Behrens, Kim A. Papp
Publikováno v:
Rheumatology and therapy. 9(5)
The objective of this work was to assess the efficacy and safety of risankizumab in psoriatic arthritis (PsA) over 76 weeks.In this double-blind, dose-ranging phase 2 study, adults with active PsA were randomized 2:2:2:1:2 to risankizumab 150 mg at w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dff492be096af10b04e3951aaa2f866
https://pubmed.ncbi.nlm.nih.gov/35931879
https://pubmed.ncbi.nlm.nih.gov/35931879
Autor:
Carlo Salvarani, Dominique Baeten, Lai-Shan Tam, David B. Hall, Alan M. Solinger, Steven J. Padula, Tae-Hwan Kim, Chandrasena Pamulapati, Paul Scholl, James Cheng-Chung Wei, Mikkel Østergaard, Joachim Sieper, Pentti Järvinen, Stella Aslanyan, Sudha Visvanathan, Yakov Datsenko
Publikováno v:
Annals of the Rheumatic Diseases
Baeten, D, Østergaard, M, Wei, J C-C, Sieper, J, Järvinen, P, Tam, L-S, Salvarani, C, Kim, T-H, Solinger, A, Datsenko, Y, Pamulapati, C, Visvanathan, S, Hall, D B, Aslanyan, S, Scholl, P & Padula, S J 2018, ' Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis : results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study ', Annals of the Rheumatic Diseases, vol. 77, no. 9, pp. 1295-1302 . https://doi.org/10.1136/annrheumdis-2018-213328
Annals of the rheumatic diseases, 77(9), 1295-1302. BMJ Publishing Group
Baeten, D, Østergaard, M, Wei, J C-C, Sieper, J, Järvinen, P, Tam, L-S, Salvarani, C, Kim, T-H, Solinger, A, Datsenko, Y, Pamulapati, C, Visvanathan, S, Hall, D B, Aslanyan, S, Scholl, P & Padula, S J 2018, ' Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis : results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study ', Annals of the Rheumatic Diseases, vol. 77, no. 9, pp. 1295-1302 . https://doi.org/10.1136/annrheumdis-2018-213328
Annals of the rheumatic diseases, 77(9), 1295-1302. BMJ Publishing Group
ObjectivesTo evaluate the efficacy and safety of risankizumab, a humanised monoclonal antibody targeting the p19 subunit of interleukin-23 (IL-23), in patients with active ankylosing spondylitis (AS).MethodsA total of 159 patients with biological-na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff74393412a5f8c7bb73f2246c6abbaa
https://hdl.handle.net/11380/1167263
https://hdl.handle.net/11380/1167263
Autor:
Stella Aslanyan, Carlos Giaquinto, J. Scott Morrow, John P. Sabo, Gabriel Anabwani, Cornelia Feiterna-Sperling, Christoph Königs
Publikováno v:
Clinical Infectious Diseases. 61:476-479
In the optional extension of clinical trial 1100.1518 39/40, human immunodeficiency virus-infected patients (aged 3 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2d71cc9e7e85a1a400820f5867725ea
https://doi.org/10.1093/cid/civ340
https://doi.org/10.1093/cid/civ340
Autor:
Maria Buti, George Kukolj, Jerry O. Stern, Christoph Sarrazin, Qiqi Deng, Stanislas Pol, Stella Aslanyan, Massimo Puoti, Mitchell L. Shiffman, Massimo Colombo, Filipe Calinas, Richard Vinisko, David R. Nelson, Antonio Olveira, Michael Roehrle, Federico J. Mensa, Pietro Andreone, Francesco Castelli
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Clinical and Experimental Gastroenterology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Clinical and Experimental Gastroenterology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Christoph Sarrazin,1 Francesco Castelli,2 Pietro Andreone,3 Maria Buti,4 Massimo Colombo,5 Stanislas Pol,6 Filipe Calinas,7 Massimo Puoti,8 Antonio Olveira,9 Mitchell Shiffman,10 Jerry O Stern,11 George Kukolj,12 Michael Roehrle,13 Stella Aslanyan,11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::491d33053f90bf78b6b9cacdd971ceb5
http://hdl.handle.net/11379/501406
http://hdl.handle.net/11379/501406
Autor:
Kennedy R. Lees, Christopher J. Weir, C S Johnston, Michael Krams, Andrew P. Grieve, Stella Aslanyan
Publikováno v:
European Journal of Neurology. 14:1-6
We sought to simultaneously confirm that substantial recovery at day 1 and day 7 after acute ischaemic stroke onset is associated with subsequent neurological deterioration in patients of the Acute Stroke Therapy by Inhibition of Neutrophils randomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f68f3fe564eba53b7831db3b98d3d1f0
https://doi.org/10.1111/j.1468-1331.2006.01549.x
https://doi.org/10.1111/j.1468-1331.2006.01549.x
Autor:
Gabriel, Anabwani, Christoph, Königs, Carlos, Giaquinto, Stella, Aslanyan, John P, Sabo, J-Scott, Morrow, Cornelia, Feiterna-Sperling
In the optional extension of clinical trial 1100.1518 39/40, human immunodeficiency virus-infected patients (aged 3 to18 years) received ≥48 weeks of treatment with extended-release nevirapine. By last visit, all patients had undetectable viral loa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::087af2b1c64b052778e62c78d41e4ffe
http://hdl.handle.net/11577/3189880
http://hdl.handle.net/11577/3189880
Autor:
Alexander White, Elaine E.L. Wang, Laura K. Ferris, Bojan Lalovic, Frank Wagner, Steven J. Padula, James G. Krueger, Sudha Visvanathan, Alan M. Solinger, Alan Menter, Paul Scholl, Stella Aslanyan, David B. Hall
Publikováno v:
The Journal of allergy and clinical immunology. 136(1)
Background IL-23 is associated with plaque psoriasis susceptibility and pathogenesis. BI 655066 is a fully human IgG 1 mAb specific for the IL-23 p19 subunit. Objective This first-in-human proof-of-concept study evaluated the clinical and biological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5046da1c682d039c2e73b12ef9d62319
https://pubmed.ncbi.nlm.nih.gov/25769911
https://pubmed.ncbi.nlm.nih.gov/25769911
Publikováno v:
Stroke. 38(4)
Background and Purpose— A prespecified interaction analysis of the neutral Intravenous Magnesium Efficacy in Stroke (IMAGES) trial revealed significant benefit from magnesium (Mg) in patients with noncortical stroke. Post hoc analysis indicated tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c685608b90c14a6a38a762ee3ad5c3
https://pubmed.ncbi.nlm.nih.gov/17347471
https://pubmed.ncbi.nlm.nih.gov/17347471
Autor:
Kennedy R. Lees, Christopher J. Weir, Matthew Walters, Gordon T. McInnes, Stella Aslanyan, J Reid
Publikováno v:
European journal of neurology. 12(7)
In addition to their lipid-lowering effects, it has been speculated that statins may also have beneficial effects on cerebral circulation and brain parenchyma during ischaemic stroke and reperfusion. We hypothesized that patients who had taken statin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28eb494a11dfac9af5d8c0d17ecf11f3
https://pubmed.ncbi.nlm.nih.gov/15958087
https://pubmed.ncbi.nlm.nih.gov/15958087
Publikováno v:
Stroke. 34(11)
Background and Purpose— Markers of low socioeconomic status (deprivation) are associated with stroke and its causes. In the United Kingdom, area-based deprivation measures are available routinely through links with postal codes. We hypothesized tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24ee8625769ddd1eddc47d2476354b8
https://pubmed.ncbi.nlm.nih.gov/14593133
https://pubmed.ncbi.nlm.nih.gov/14593133